(Q37362655)

19 August 2017

1 reference

title

Managing TB in the 21st century: existing and novel drug therapies (English)

1 reference

19 August 2017

Elizabeth S Guy

1

1 reference

19 August 2017

Antara Mallampalli

series ordinal

2

1 reference

19 August 2017

publication date

1 December 2008

1 reference

Therapeutic advances in respiratory disease

19 August 2017

published in

1 reference

19 August 2017

volume

2

1 reference

19 August 2017

issue

6

1 reference

19 August 2017

page(s)

401-408

1 reference

In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Molecular approaches to target discovery:--evaluating targets for anti-tuberculosis drug discovery programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Long term efficacy of DOTS regimens for tuberculosis: systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Linezolid for the treatment of multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Structure-based approaches to drug discovery against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Lack of weight gain and relapse risk in a large tuberculosis treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Diarylquinolines target subunit c of mycobacterial ATP synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

The diagnosis and therapy of tuberculosis during the past 100 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Fluoroquinolones for the treatment of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Patient adherence to tuberculosis treatment: a systematic review of qualitative research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

High throughput crystallography of TB drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Treatment outcomes of patients with HIV and tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Antimycobacterial activities of oxazolidinones: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

Fluoroquinolones for treating tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808099522

21 January 2018

Identifiers

DOI

10.1177/1753465808099522

1 reference

19 August 2017

1 reference